Recent breakthroughs in PrEP and other HIV prevention options have revolutionised the care of patients, but concerning new data has revealed that resistance to the treatment is on the rise. Read More...
Recent research shows that taking Truvada (tenofovir DF 300mg/ emtricitabine 200mg) daily reduces HIV. Will this see the end of HIV? The treatment is called PrEP- Pre-Exposure Prophylaxis. Read More...
The fight against HIV has taken a new direction with PrEP, which alongside other measures intends to reduce HIV incidence, transmission, mortality and morbidity. Read More...
Medical Forum uses cookies to improve your experience. For more information, click on cookie settings. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
